Clearmind Medicine Inc. Foreign Exchange Loss
Clearmind Medicine Inc. (CMND) reported Foreign Exchange Loss of $6.03 thousand for the 12-month period ending 2024-10-31, per its 20-F filed 2025-01-22.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ForeignExchangeLoss · last filed 2025-01-22
CAD
| Period end | Foreign Exchange Loss 12 month |
|---|---|
| 2022-10-31 | 552.00 CAD 20-F · filed 2023-02-06 |
| 2021-10-31 | 33.53K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Foreign Exchange Loss 12 month |
|---|---|
| 2024-10-31 | $6.03K 20-F · filed 2025-01-22 |
| 2023-10-31 | $78.14K 20-F · filed 2025-01-22 |
| 2022-10-31 | $404.00 20-F · filed 2025-01-22 |
| 2021-10-31 | $24.56K 20-F/A · filed 2024-03-18 |